Oncomatryx fights cancer with precision medicine

The biotech firm develops the first conjugated antibody in Europe against pancreatic, lung and breast tumours The Basque biotech company Oncomatryx, which specialises in the development of pioneering drugs against invasive tumours, has recently developed the first conjugated antibody in Europe that directly attacks the cells surrounding the tumour. In Spain alone, some 8,700 cases…